Sotuvning sof marjinal rentabelligi: Codexis, Inc. (CDXS)

Codexis (CDXS) korporativ emblemasi va logotipi

Codexis, Inc. (CDXS) o'zining yetilish bosqichida bo'lib, bioinzhenerlik orqali farmatsevtika segmentini kengaytirmoqda. Sof foyda marjasi moliyaviy barqarorlikni namoyish etmoqda va uning oxirgi qiymati -21.80 deb qayd etilgan. Asosiy ko'rsatkichlarning o'sishi DNK sintezini avtomatlashtirish uchun CodeEvolver AI platformalarining joriy etilishi, shuningdek, kimyoviy zavod xarajatlarini optimallashtiradigan va dori vositalarining chiqarilishini tezlashtiradigan noyob oqsillarning yaratilishi hisobiga ta'minlanmoqda.

Codexis Inc (CDXS) - Sotuvning sof rentabelligi 04.07.2022dan 19.11.2026gacha

codexis.com (CDXS) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Codexis, Inc.
Codexis, Inc. ishlab chiqargan mahsulot

Investorlar biocatalysis sohasining yetakchisi Codexis, Inc. (CDXS) dan B2B sektori uchun dori sintezi xarajatlarini optimallashtiruvchi CodeEvolver texnologiyasini joriy etish orqali yuqori daromadlar kutmoqdalar. Choraklik foyda marjalari har bir dollarlik tushumning sof foyda qismini aks ettirib, xarajatlarni nazorat qilish samaradorligini va biznesning texnologik ustunlikni yakuniy moliyaviy natijaga aylantirish bo'yicha haqiqiy qobiliyatini baholash imkonini beradi.

Muhim raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX